Bronchodilator Agents

• 

  Subject Areas on Research

  • 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. 
  • A review of the use of adjunctive therapies in severe acute asthma exacerbation in critically ill children. 
  • Acute effects of inhaled nitric oxide on pulmonary and cardiac function in preterm infants with evolving bronchopulmonary dysplasia. 
  • Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. 
  • Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report. 
  • Aerosol delivery in intubated, mechanically ventilated patients. 
  • Airway mucus membrane: effects of beta-adrenergic and anticholinergic stimulation. 
  • An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department. 
  • An appraisal of pharmacoeconomic evidence of maintenance therapy for COPD. 
  • Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. 
  • Asthma outcomes: pulmonary physiology. 
  • Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. 
  • Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. 
  • Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. 
  • Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. 
  • Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. 
  • Bronchiolitis. 
  • Bronchiolitis. 
  • Bronchodilators in asthma. 
  • Bronchodilators in heart failure patients with COPD: is it time for a clinical trial? 
  • Characterization of the airway smooth muscle muscarinic receptor in vivo. 
  • Childhood asthma clusters and response to therapy in clinical trials. 
  • Chronic obstructive pulmonary disease management: the evidence base. 
  • Chronic obstructive pulmonary disease: emerging medical therapies. 
  • Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. 
  • Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. 
  • Contamination of nebulizer equipment with cockroach allergen: there's a bug in the system! 
  • Daily versus as-needed corticosteroids for mild persistent asthma. 
  • Dispensing home nebulizers for acute wheezing from the hospital is cost-effective. 
  • Early management of acute severe asthma. 
  • Effect of lidocaine on endothelin-1-mediated airway smooth muscle contraction in the rat trachea. 
  • Efficacy of esomeprazole for treatment of poorly controlled asthma. 
  • Efficacy of inhaled nitric oxide in preterm neonates. 
  • Emergent management of acute asthma. 
  • Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. 
  • Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration. 
  • G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation. 
  • GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. 
  • Impact of Age and Sex on Response to Asthma Therapy. 
  • Impact of race on asthma treatment failures in the asthma clinical research network. 
  • Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. 
  • Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. 
  • Inhaled nitric oxide: plenty of data, no consensus. 
  • Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. 
  • Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche. 
  • Management of acute exacerbations of chronic obstructive pulmonary disease. 
  • Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. 
  • Mechanical ventilation strategies in the management of congenital diaphragmatic hernia. 
  • Meeting the obligation to balance bioethics and clinical trial design in asthma. 
  • Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. 
  • Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. 
  • Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. 
  • Physician-targeted program on inhaled therapy for childhood asthma. 
  • Predictors of response to tiotropium versus salmeterol in asthmatic adults. 
  • Protection from experimental asthma by an endogenous bronchodilator. 
  • Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. 
  • Risk indexes for exacerbations and hospitalizations due to COPD. 
  • Safety of a peanut oral immunotherapy protocol in children with peanut allergy. 
  • Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. 
  • Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. 
  • Stress, ADCYAP1R1, and Childhood Asthma. No Sigh of Relief. 
  • The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. 
  • The effect of exposure to wood smoke on outcomes of childhood pneumonia in Botswana. 
  • The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. 
  • The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 
  • The effects of direct-to-consumer advertising on medication use among Medicaid children with asthma. 
  • Tiotropium (Spiriva) for COPD. 
  • Tiotropium bromide step-up therapy for adults with uncontrolled asthma. 
  • Treatment of acute bronchitis in adults. A national survey of family physicians. 
  • Using Hyperpolarized 129Xe MRI to Quantify the Pulmonary Ventilation Distribution. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology